Search Results - "RAVULA JYOTHSNA" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study

Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study

by Nirogi, Ramakrishna, Ieni, John, Goyal, Vinod Kumar, Ravula, Jyothsna, Jetta, Satish, Shinde, Anil, Jayarajan, Pradeep, Benade, Vijay, Palacharla, Veera Raghava Chowdary, Dogiparti, Dhanunjay Kumar, Jasti, Venkat, Atri, Alireza, Cummings, Jeffrey
Published in Alzheimer's & dementia : translational research & clinical interventions (2022)

Get full text

Journal Article

0609 Samelisant, Histamine 3 Receptor Agonist for the Potential Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy

0609 Samelisant, Histamine 3 Receptor Agonist for the Potential Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy

by Nirogi, Ramakrishna, Ravula, Jyothsna, Jayarajan, Pradeep, Goyal, Vinod Kumar, Jetta, Satish, Shinde, Anil, Benade, Vijay
Published in Sleep (New York, N.Y.) (29.05.2023)

Get full text

Journal Article

0649 Samelisant Improves the Symptoms of Excessive Daytime Sleepiness in Narcolepsy: Results from a Phase-2 Study

0649 Samelisant Improves the Symptoms of Excessive Daytime Sleepiness in Narcolepsy: Results from a Phase-2 Study

by Nirogi, Ramakrishna, Ravula, Jyothsna, Jayarajan, Pradeep, Goyal, Vinod Kumar, Benade, Vijay, Jetta, Satish, Shinde, Anil, Dogiparti, Dhanunjay, Subramanian, Ramkumar, Kalaikadhiban, Ilayaraja, Jasti, Venkat
Published in Sleep (New York, N.Y.) (20.04.2024)

Get full text

Journal Article

0624 Samelisant (SUVN-G3031), Baseline Characteristics from a Phase-2 Study Evaluating Efficacy and Safety in Patients with Narcolepsy

0624 Samelisant (SUVN-G3031), Baseline Characteristics from a Phase-2 Study Evaluating Efficacy and Safety in Patients with Narcolepsy

by Nirogi, Ramakrishna, Ravula, Jyothsna, Jayarajan, Pradeep, Goyal, Vinod Kumar, Jetta, Satish, Shinde, Anil, Benade, Vijay, Jasti, Venkat
Published in Sleep (New York, N.Y.) (25.05.2022)

Get full text

Journal Article

Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects

Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects

by Nirogi, Ramakrishna, Ravula, Jyothsna, Benade, Vijay, Goyal, Vinod Kumar, Pandey, Santosh Kumar, Dogiparti, Dhanunjay, Jayarajan, Pradeep, Kalaikadhiban, Ilayaraja, Jetta, Satish, Palacharla, Veera Raghava Chowdary
Published in Cancer chemotherapy and pharmacology (01.03.2024)

Get full text

Journal Article

506 Samelisant: Baseline Characteristics from a Phase 2 Study Evaluating Efficacy and Safety in Patients with Narcolepsy

506 Samelisant: Baseline Characteristics from a Phase 2 Study Evaluating Efficacy and Safety in Patients with Narcolepsy

by Nirogi, Ramakrishna, Ravula, Jyothsna, Jayarajan, Pradeep, Jetta, Satish, Bhyrapuneni, Gopinadh, Benade, Vijay, Shinde, Anil, Goyal, Vinod
Published in Sleep (New York, N.Y.) (03.05.2021)

Get full text

Journal Article

1021 Samelisant: Clinician and Patient Global Impression from a Double-Blind, Phase-2 Study in Patients with Narcolepsy

1021 Samelisant: Clinician and Patient Global Impression from a Double-Blind, Phase-2 Study in Patients with Narcolepsy

by Nirogi, Ramakrishna, Jayarajan, Pradeep, Goyal, Vinod Kumar, Ravula, Jyothsna, Jetta, Satish, Shinde, Anil, Benade, Vijay, Abraham, Renny, Palacharla, Veera Raghava Chowdary, Pandey, Santosh Kumar, Mohammed, Abdul Rasheed, Jasti, Venkat
Published in Sleep (New York, N.Y.) (20.04.2024)

Get full text

Journal Article

Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy

Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy

by Nirogi, Ramakrishna, Shinde, Anil, Goyal, Vinod Kumar, Ravula, Jyothsna, Benade, Vijay, Jetta, Satish, Pandey, Santosh Kumar, Subramanian, Ramkumar, Chowdary Palacharla, Veera Raghava, Mohammed, Abdul Rasheed, Abraham, Renny, Dogiparti, Dhanunjay Kumar, Kalaikadhiban, Ilayaraja, Jayarajan, Pradeep, Jasti, Venkat, Bogan, Richard K.
Published in Sleep medicine (01.12.2024)

Get full text

Journal Article

Masupirdine (SUVN‐502) for the Potential Treatment of Agitation in Patients with Dementia of the Alzheimer’s Type: Preliminary Efficacy and Phase‐3 Study Design

Masupirdine (SUVN‐502) for the Potential Treatment of Agitation in Patients with Dementia of the Alzheimer’s Type: Preliminary Efficacy and Phase‐3 Study Design

by Nirogi, Ramakrishna, Abraham, Renny, Ravula, Jyothsna, Jetta, Satish, Benade, Vijay, Shinde, Anil K, Rasheed, Mohammed Abdul, Badange, Rajesh Kumar, Goyal, Vinod Kumar, Palacharla, Veera Raghava Chowdary, Subramanian, Ramkumar, Jayarajan, Pradeep
Published in Alzheimer's & dementia (01.12.2023)

Get full text

Journal Article

Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses

Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses

by Nirogi, Ramakrishna, Jayarajan, Pradeep, Benade, Vijay, Shinde, Anil, Goyal, Vinod Kumar, Jetta, Satish, Ravula, Jyothsna, Abraham, Renny, Grandhi, Venkata Ramalingayya, Subramanian, Ramkumar, Pandey, Santosh Kumar, Badange, Rajesh Kumar, Mohammed, Abdul Rasheed, Jasti, Venkat, Ballard, Clive, Cummings, Jeffrey
Published in International journal of geriatric psychiatry (01.10.2022)

Get full text

Journal Article

Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects

Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects

by Nirogi, Ramakrishna, Benade, Vijay, Goyal, Vinod Kumar, Pandey, Santosh Kumar, Mohammed, Abdul Rasheed, Shinde, Anil, Dogiparti, Dhanunjay, Ravula, Jyothsna, Jetta, Satish, Palacharla, Veera Raghava Chowdary
Published in Clinical drug investigation (01.09.2022)

Get full text

Journal Article

Masupirdine (SUVN‐502): A promising clinical candidate for the management of agitation in Alzheimer’s dementia

Masupirdine (SUVN‐502): A promising clinical candidate for the management of agitation in Alzheimer’s dementia

by Nirogi, Ramakrishna, Jayarajan, Pradeep, Tadiparthi, Jayaprakash, Shinde, Anil K, Rasheed, Mohammed Abdul, Goyal, Vinod Kumar, Bhyrapuneni, Gopinadh, Benade, Vijay, Palacharla, Veera Raghava Chowdary, Ravula, Jyothsna, Jetta, Satish
Published in Alzheimer's & dementia (01.12.2021)

Get full text

Journal Article

First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects

First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects

by Nirogi, Ramakrishna, Bhyrapuneni, Gopinadh, Muddana, Nageswara Rao, Goyal, Vinod Kumar, Pandey, Santosh Kumar, Mohammed, Abdul Rasheed, Ravula, Jyothsna, Jetta, Satish, Palacharla, Veera Raghava Chowdary
Published in Clinical drug investigation (01.05.2021)

Get full text

Journal Article

Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses

Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses

by Nirogi, Ramakrishna, Mudigonda, Koteshwara, Bhyrapuneni, Gopinadh, Muddana, Nageswara Rao, Shinde, Anil, Goyal, Vinod Kumar, Pandey, Santosh Kumar, Mohammed, Abdul Rasheed, Ravula, Jyothsna, Jetta, Satish, Palacharla, Veera Raghava Chowdary
Published in Clinical drug investigation (01.07.2020)

Get full text

Journal Article

0053 SUVN-G3031: Safety, Tolerability and Pharmacokinetics of a Potent and Selective Histamine H3 Receptor Inverse Agonist - Single and Multiple Ascending Doses in Healthy Subjects

0053 SUVN-G3031: Safety, Tolerability and Pharmacokinetics of a Potent and Selective Histamine H3 Receptor Inverse Agonist - Single and Multiple Ascending Doses in Healthy Subjects

by Nirogi, Ramakrishna, Shinde, Anil, Mudigonda, Koteshwara, Bhyrapuneni, Gopinadh, Muddana, Nageswara Rao, Palacharla, Raghava Chowdary, Ajjala, Devender Reddy, Goyal, Vinod Kumar, Ravula, Jyothsna, Jetta, Satish, Mohammed, Abdul Rasheed
Published in Sleep (New York, N.Y.) (13.04.2019)

Get full text

Journal Article

Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study

Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study

by Nirogi, Ramakrishna, Goyal, Vinod Kumar, Benade, Vijay, Subramanian, Ramkumar, Ravula, Jyothsna, Jetta, Satish, Shinde, Anil, Pandey, Santosh Kumar, Jayarajan, Pradeep, Jasti, Venkat, Cummings, Jeffrey
Published in Neurology and therapy (01.12.2022)

Get full text

Journal Article

히스타민-3 수용체 역작용제에 의한 치료 방법

히스타민-3 수용체 역작용제에 의한 치료 방법

by NIROGI RAMAKRISHNA, SHINDE ANIL KARBHARI, JAYARAJAN PRADEEP, BENADE VIJAY SIDRAM, DARIPELLI SAIVISHAL, RAVULA JYOTHSNA, JASTI VENKATESWARLU
Year of Publication 08.02.2021

Get full text

Patent

First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT 4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects

First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT 4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects

by Nirogi, Ramakrishna, Bhyrapuneni, Gopinadh, Muddana, Nageswara Rao, Goyal, Vinod Kumar, Pandey, Santosh Kumar, Mohammed, Abdul Rasheed, Ravula, Jyothsna, Jetta, Satish, Palacharla, Veera Raghava Chowdary
Published in Clinical drug investigation (31.03.2021)

Get full text

Journal Article

치매 환자의 행동 및 심리적 증상 치료

치매 환자의 행동 및 심리적 증상 치료

by NIROGI RAMAKRISHNA, GOYAL VINOD KUMAR, SHINDE ANIL KARBHARI, JAYARAJAN PRADEEP, MOHAMMED ABDUL RASHEED, PALACHARLA RAGHAVA CHOWDARY, BENADE VIJAY SIDRAM, JETTA SATISH, PANDEY SANTOSH KUMAR, SUBRAMANIAN RAMKUMAR, RAVULA JYOTHSNA, JASTI VENKATESWARLU
Year of Publication 02.08.2022

Get full text

Patent

AMORPHOUS PHARMACEUTICAL COMPOSITIONS OF ABIRATERONE ACETATE

AMORPHOUS PHARMACEUTICAL COMPOSITIONS OF ABIRATERONE ACETATE

by DOGIPARTI, DHANUNJAY KUMAR, JASTI, VENKATESWARLU, NIROGI, RAMAKRISHNA, MUDIGONDA, KOTESHWARA, RAVULA, JYOTHSNA
Year of Publication 11.06.2024

Get full text

Patent

1
2
3
4
5
6
Next
[6]